Aktiesnakken — August 2010
-
ved udgangen af året. MEN det er uden den kapital fremskaffelse de pt er i gang med at skaffe
-
Milestones for resten af året er bla start af fase 3 i de novo nyre og resultater fra fase 2 opfølgnings studiet i de novo lever patiente
-
Der er ingen spørgsmål i Q&A.... Analytikere er med stor sandsynlighed travlt optaget af Genmab
-
Så nok lidt uheldigt tidspunkt for CC. Normalt tid i dk er også kl 15 og ikkke 1730
-
Over and out herfra
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind